APOFORE
Apofore is developing novel therapeutics for Type 2 diabetes based on the naturally occurring protein, Apolipoprotein A-IV (apo A-IV). The company’s approach is based on the discovery by its scientific founder Patrick Tso, PhD, at the University of Cincinnati, of apo A-IV as an important regulator of insulin secretion and glucose homeostasis. Recombinant apo A-IV, the company’s lead therapeutic is in preclinical development.
APOFORE
Industry:
Biotechnology Diabetes Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.apofore.com
Total Employee:
1+
Status:
Active
Contact:
6094303922
Email Addresses:
[email protected]
Total Funding:
500 K USD
Technology used in webpage:
Google Font API Domain Not Resolving Google Cloud OpenResty GoDaddy CDN
Similar Organizations
SolAeroMed
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases.
Current Employees Featured
